STAAR Surgical Company

NasdaqGM STAA

STAAR Surgical Company Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending September 27, 2024: 49,422,750

STAAR Surgical Company Shares (Diluted, Weighted) is 49,422,750 for the Trailing 12 Months (TTM) ending September 27, 2024, a -0.04% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

STAAR Surgical Company Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending September 29, 2023 was 49,443,750, a 0.12% change year over year.
STAAR Surgical Company Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending September 30, 2022 was 49,384,500, a 0.22% change year over year.
STAAR Surgical Company Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending October 01, 2021 was 49,276,000, a 6.26% change year over year.
STAAR Surgical Company Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending October 02, 2020 was 46,374,000, a -1.06% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

NasdaqGM: STAA

STAAR Surgical Company

CEO	Mr. Thomas G. Frinzi
IPO Date	Feb. 24, 1992
Location	United States
Headquarters	25651 Atlantic Ocean Drive
Employees	1,056
Sector	Consumer Discretionary
Industries Eyewear

Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Key trends

Past 5 years